A. Samer Al-Homsi, a leader in hematology, was appointed as system chief of blood and marrow transplant and cellular therapy at the Northwell Health Cancer Institute.
Marking a new era of non-invasive medical interventions, the Northwell Health Cancer Institute is investing $1.2 million in the development of cutting-edge histotripsy technology to treat some liver cancer tumors without surgery. This innovative approach uses targeted ultrasound beams to create microbubbles within tumors, effectively disrupting and destroying diseased cells without the need for incisions.
